CA2005291A1 - Instruments de diagnostic du virus de la peritonite infectieuse des felins - Google Patents

Instruments de diagnostic du virus de la peritonite infectieuse des felins

Info

Publication number
CA2005291A1
CA2005291A1 CA2005291A CA2005291A CA2005291A1 CA 2005291 A1 CA2005291 A1 CA 2005291A1 CA 2005291 A CA2005291 A CA 2005291A CA 2005291 A CA2005291 A CA 2005291A CA 2005291 A1 CA2005291 A1 CA 2005291A1
Authority
CA
Canada
Prior art keywords
fipv
diagnostic tools
infectious peritonitis
feline infectious
peritonitis virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2005291A
Other languages
English (en)
Other versions
CA2005291C (fr
Inventor
Beverly Dale
Miles Yamanaka
William N. Acree
Lloyd G. Chavez, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Scios LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2005291A1 publication Critical patent/CA2005291A1/fr
Application granted granted Critical
Publication of CA2005291C publication Critical patent/CA2005291C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/102—Coronaviridae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002005291A 1988-12-30 1989-12-12 Instruments de diagnostic du virus de la peritonite infectieuse des felins Expired - Lifetime CA2005291C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29252788A 1988-12-30 1988-12-30
US292,527 1988-12-30

Publications (2)

Publication Number Publication Date
CA2005291A1 true CA2005291A1 (fr) 1990-06-30
CA2005291C CA2005291C (fr) 1999-01-26

Family

ID=23125039

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005291A Expired - Lifetime CA2005291C (fr) 1988-12-30 1989-12-12 Instruments de diagnostic du virus de la peritonite infectieuse des felins

Country Status (12)

Country Link
US (2) US5780266A (fr)
EP (1) EP0376744B1 (fr)
JP (1) JP2903129B2 (fr)
AT (1) ATE126537T1 (fr)
AU (1) AU640356B2 (fr)
CA (1) CA2005291C (fr)
DE (1) DE68923862T2 (fr)
DK (1) DK174187B1 (fr)
ES (1) ES2078246T3 (fr)
GR (1) GR3017770T3 (fr)
IE (1) IE67650B1 (fr)
NZ (1) NZ231850A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005291C (fr) * 1988-12-30 1999-01-26 Beverly Dale Instruments de diagnostic du virus de la peritonite infectieuse des felins
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
EP0524672A1 (fr) * 1991-06-27 1993-01-27 Duphar International Research B.V Vaccin contre le CCV
CA2128698A1 (fr) * 1992-02-18 1993-08-19 Richard G. Olsen Vaccin contre la peritonite feline infectieuse et methode de preparation
ES2182827T3 (es) * 1992-05-08 2003-03-16 Pfizer Gen del virus corona canino y usos del mismo.
JPH07508176A (ja) * 1992-05-08 1995-09-14 ファイザー・インコーポレイテッド 普遍コロナウイルスワクチン
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
RU2236678C2 (ru) * 2002-11-04 2004-09-20 Красноярская государственная медицинская академия Способ прогноза исхода перитонита средней степени тяжести по содержанию некоторых жирных кислот в лимфоцитах больных
US8541003B2 (en) 2003-06-20 2013-09-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
RU2480756C2 (ru) * 2011-02-10 2013-04-27 Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования течения послеоперационного периода у больных с перитонитом
WO2015077717A1 (fr) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions et méthodes pour diagnostiquer, évaluer et traiter un cancer au moyen d'un état de méthylation d'adn
WO2015085147A1 (fr) 2013-12-05 2015-06-11 The Broad Institute Inc. Typage de gènes polymorphes et détection de changements somatiques à l'aide de données de séquençage
KR20230076867A (ko) 2013-12-20 2023-05-31 더 브로드 인스티튜트, 인코퍼레이티드 신생항원 백신과의 병용 요법
EP3234130B1 (fr) 2014-12-19 2020-11-25 The Broad Institute, Inc. Procédé pour profiler le répertoire de récepteurs de cellulles t.
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
IL294183B2 (en) 2015-05-20 2023-10-01 Dana Farber Cancer Inst Inc shared neoantigens
TW202241500A (zh) 2015-06-09 2022-11-01 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
AU2017254477A1 (en) 2016-04-18 2018-11-01 Jennifer G. ABELIN Improved HLA epitope prediction
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20220062394A1 (en) 2018-12-17 2022-03-03 The Broad Institute, Inc. Methods for identifying neoantigens
US12394502B2 (en) 2019-10-02 2025-08-19 The General Hospital Corporation Method for predicting HLA-binding peptides using protein structural features

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192271A (en) * 1978-11-30 1983-03-15 Wellcome Found Inactivated feline infectious peritonitis (fip) vaccine
DK507079A (da) * 1978-11-30 1980-05-31 Wellcome Found Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
WO1987004624A1 (fr) * 1986-02-06 1987-08-13 Schering Corporation Vaccin contre la peritonite infectieuse des felins
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
CA2005291C (fr) * 1988-12-30 1999-01-26 Beverly Dale Instruments de diagnostic du virus de la peritonite infectieuse des felins
CA2011025A1 (fr) * 1989-03-01 1990-09-01 Terry R. Beardsley Vaccin contre la peritonite infectieuse des felins
HUT54733A (en) * 1989-07-12 1991-03-28 Duphar Int Res Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes

Also Published As

Publication number Publication date
JPH02291273A (ja) 1990-12-03
CA2005291C (fr) 1999-01-26
JP2903129B2 (ja) 1999-06-07
EP0376744B1 (fr) 1995-08-16
AU4691589A (en) 1990-07-05
IE894222L (en) 1990-06-30
AU640356B2 (en) 1993-08-26
DE68923862D1 (de) 1995-09-21
DE68923862T2 (de) 1996-02-08
ES2078246T3 (es) 1995-12-16
ATE126537T1 (de) 1995-09-15
US5811104A (en) 1998-09-22
IE67650B1 (en) 1996-04-17
GR3017770T3 (en) 1996-01-31
US5780266A (en) 1998-07-14
EP0376744A1 (fr) 1990-07-04
NZ231850A (en) 1992-10-28
DK174187B1 (da) 2002-08-26
DK672789D0 (da) 1989-12-29
DK672789A (da) 1990-07-01

Similar Documents

Publication Publication Date Title
CA2005291A1 (fr) Instruments de diagnostic du virus de la peritonite infectieuse des felins
BR9608615A (pt) Vacinas de vírus sincicial respiratório de ácido nucléico
EP1394256A3 (fr) Séquences génomiques de l'HCV comme moyens diagnostiques et thérapeutiques
ATE195076T1 (de) Verfahren zur isolierung von haemopnilus influenzae protein-e
BE2014C050I2 (en) Circovirus sequences associated with piglet weight loss disease (PWD)
DE3768833D1 (de) Verfahren zur herstellung von hcmv-glykoproteinen, antikoerper dagegen und hcmv-vakzine und dazu zu verwendende rekombinante vektoren.
AU571128B2 (en) Expression of immunologically reactive aids viral protein
DK482788D0 (da) Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
DE58906162D1 (de) Verfahren zur Herstellung eines gegebenenfalls substituierten Chinacridons.
AU7717087A (en) Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
EP0432220A4 (en) Vaccines and diagnostic assays for haemophilus influenzae
NO20005217D0 (no) DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
CA2012414A1 (fr) Vaccin contre le virus de la peste porcine et diagnostic
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE115964T1 (de) Non-a non-b sequenzen.
DK76688A (da) Vaccine indeholdende f-proteinet fra aids-virus
AU8405798A (en) A swine hepatitis e virus and uses thereof
WO1999024466A3 (fr) Peptides multimeres derives de proteines d'enveloppe de virus d'hepatite c (hcv) a des fins de diagnostic et de vaccination
EP0288198A3 (fr) Production de peptide
FI920030A7 (fi) IBDV-proteiiniin liittyviä spesifisiä DNA-sekvenssejä sekä vektoreita, isäntiä ja rokotteita

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry